Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions
Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

megamenu-company-2

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

Explore our Resources

Veranex News

2 min read

Veranex Announces Acquisition of IMMR

Gary Keeler: Oct 12, 2021, 12:15:00 AM

RALEIGH, N.C.; Oct. 12, 2021 – Veranex, the first concept-to-commercialization global service provider dedicated to the MedTech industry, today announced the acquisition of IMMR, a leading preclinical science organization that provides preclinical...

Read More

1 min read

Veranex Announces Acquisition of Experien Group

Gary Keeler: Aug 3, 2021, 12:15:00 AM

RALEIGH, N.C.; August 3, 2021 – Veranex the first concept-to-commercialization global service provider dedicated to the medtech industry, today...

Read More

3 min read

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization MedTech Services Company

Gary Keeler: Jun 16, 2021, 12:15:00 AM

RALEIGH, N.C.; June 16, 2021 – Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to...

Read More

1 min read

Quartesian Signs Global Medical Technology Company to Multiyear Clinical Data Management Services Agreement

Gary Keeler: Jun 13, 2021, 12:15:00 AM

PRINCETON, N.J., April 13, 2021 — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device...

Read More

1 min read

Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial

Gary Keeler: Jun 16, 2020, 12:15:00 AM

PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and...

Read More
Prev 1 2 3